These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20121678)

  • 1. Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the Greater Green Triangle Risk Factor Study.
    Janus ED; Tideman PA; Dunbar JA; Kilkkinen A; Bunker SJ; Philpot B; Tirimacco R; Mc Namara K; Heistaro S; Laatikainen T
    Med J Aust; 2010 Feb; 192(3):127-32. PubMed ID: 20121678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
    Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
    Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study.
    Liu X; Yu S; Mao Z; Li Y; Zhang H; Yang K; Zhang H; Liu R; Qian X; Li L; Bie R; Wang C
    Lipids Health Dis; 2018 May; 17(1):119. PubMed ID: 29788966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS Findings.
    Shehab A; Al-Rasadi K; Arafah M; Al-Hinai AT; Al Mahmeed W; Bhagavathula AS; Al Tamimi O; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Alawadhi M; Amin H; Al-Hashmi K; Oulhaj A
    Curr Vasc Pharmacol; 2018; 16(4):368-375. PubMed ID: 28677510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey.
    Zdrojewski T; Solnica B; Cybulska B; Bandosz P; Rutkowski M; Stokwiszewski J; Gaciong Z; Banach M; Wojtyniak B; Pencina M; Wyrzykowski B
    Kardiol Pol; 2016; 74(3):213-23. PubMed ID: 27004543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
    Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lipid-lowering therapy on the prevalence of dyslipidaemia in patients at high-risk of cardiovascular events in UK primary care - a retrospective database study.
    Jameson K; Amber V; D'Oca K; Mills D; Giles A; Ambegaonkar B
    Int J Clin Pract; 2013 Dec; 67(12):1228-37. PubMed ID: 23944233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and control of dyslipidaemia among diabetic patients with microalbuminuria in a Chinese hospital.
    Wang SH; Wang L; Zhou Y; Guo YJ; Yuan Y; Li FF; Huang Y; Xia WQ
    Diab Vasc Dis Res; 2013 Mar; 10(2):169-78. PubMed ID: 22906862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy: the South African Not at Goal study (SA-NAG).
    Ramjeeth A; Butkow N; Raal FJ; Maholwana-Mokgatlhe M
    Cardiovasc J Afr; 2008; 19(2):88-94. PubMed ID: 18516354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five year trends in dyslipidaemia prevalence and management in Switzerland: the CoLaus study.
    Antiochos P; Marques-Vidal P; Waeber G; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):1007-15. PubMed ID: 26321470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alarming rise in prevalence of atherogenic dyslipidaemia in the black population of Cape Town: the Cardiovascular Risk in Black South Africans (CRIBSA) study.
    Peer N; Steyn K; Lombard C; Gaziano T; Levitt N
    Eur J Prev Cardiol; 2014 Dec; 21(12):1549-56. PubMed ID: 23881149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: A cross-sectional study.
    Xing L; Jing L; Tian Y; Yan H; Zhang B; Sun Q; Dai D; Shi L; Liu D; Yang Z; Liu S
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2262-2270. PubMed ID: 32988725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.
    Zhang FL; Xing YQ; Wu YH; Liu HY; Luo Y; Sun MS; Guo ZN; Yang Y
    Lipids Health Dis; 2017 Mar; 16(1):61. PubMed ID: 28330492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS).
    Zhao S; Wang Y; Mu Y; Yu B; Ye P; Yan X; Li Z; Wei Y; Ambegaonakr BM; Hu D;
    Atherosclerosis; 2014 Aug; 235(2):463-9. PubMed ID: 24950001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: a community based survey.
    Asiki G; Murphy GA; Baisley K; Nsubuga RN; Karabarinde A; Newton R; Seeley J; Young EH; Kamali A; Sandhu MS
    PLoS One; 2015; 10(5):e0126166. PubMed ID: 25974077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
    Halcox JP; Banegas JR; Roy C; Dallongeville J; De Backer G; Guallar E; Perk J; Hajage D; Henriksson KM; Borghi C
    BMC Cardiovasc Disord; 2017 Jun; 17(1):160. PubMed ID: 28623902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of dyslipidemia in the Iraqi adult population.
    Mula-Abed WA; Chilmeran SK
    Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs.
    Laforest L; Souchet T; Moulin P; Ritleng C; Desamericq G; Le Jeunne P; Schwalm MS; Van Ganse E
    Arch Cardiovasc Dis; 2009 Jan; 102(1):43-50. PubMed ID: 19233108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein lipids and the prevalence of hyperlipidaemia in rural India.
    Gupta R; Gupta HP; Kumar N; Joshi AK; Gupta VP
    J Cardiovasc Risk; 1994 Aug; 1(2):179-84. PubMed ID: 7606632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.